CL2014003510A1 - Composición con factores de crecimiento obtenidos a partir del plasma sanguíneo destinada al tratamiento de enfermedades neurodegenerativas. - Google Patents
Composición con factores de crecimiento obtenidos a partir del plasma sanguíneo destinada al tratamiento de enfermedades neurodegenerativas.Info
- Publication number
- CL2014003510A1 CL2014003510A1 CL2014003510A CL2014003510A CL2014003510A1 CL 2014003510 A1 CL2014003510 A1 CL 2014003510A1 CL 2014003510 A CL2014003510 A CL 2014003510A CL 2014003510 A CL2014003510 A CL 2014003510A CL 2014003510 A1 CL2014003510 A1 CL 2014003510A1
- Authority
- CL
- Chile
- Prior art keywords
- treatment
- composition
- growth factors
- blood plasma
- neurodegenerative diseases
- Prior art date
Links
- 239000003102 growth factor Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000004770 neurodegeneration Effects 0.000 title 1
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
- 210000002381 plasma Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/19—Platelets; Megacaryocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201200810A ES2442242B1 (es) | 2012-08-09 | 2012-08-09 | Composición con factores de crecimiento destinada al tratamiento intranasal de una enfermedad neurodegenerativa u otra patología del sistema nervioso central, y su método de fabricación. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2014003510A1 true CL2014003510A1 (es) | 2015-05-04 |
Family
ID=49111229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2014003510A CL2014003510A1 (es) | 2012-08-09 | 2014-12-23 | Composición con factores de crecimiento obtenidos a partir del plasma sanguíneo destinada al tratamiento de enfermedades neurodegenerativas. |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20140044795A1 (enExample) |
| EP (1) | EP2883569B1 (enExample) |
| JP (1) | JP6339568B2 (enExample) |
| KR (1) | KR102149162B1 (enExample) |
| CN (1) | CN104519961A (enExample) |
| AR (1) | AR092086A1 (enExample) |
| BR (1) | BR112015002760A2 (enExample) |
| CA (1) | CA2881075A1 (enExample) |
| CL (1) | CL2014003510A1 (enExample) |
| CO (1) | CO7170177A2 (enExample) |
| ES (2) | ES2442242B1 (enExample) |
| IN (1) | IN2014MN02675A (enExample) |
| MX (1) | MX357828B (enExample) |
| PE (1) | PE20150616A1 (enExample) |
| RU (1) | RU2696497C2 (enExample) |
| TW (1) | TWI649084B (enExample) |
| WO (1) | WO2014023860A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018112672A1 (es) | 2016-12-21 | 2018-06-28 | Universidad De Chile | Virus aav/igf2, metodo de tratamiento genetico y su uso en enfermedades relacionadas con mal plegamiento de proteinas tal como la enfermedad de huntington |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2252993T3 (es) * | 1998-12-09 | 2006-05-16 | Chiron Corporation | Administracion de agentes neurotroficos al sistema nervioso central. |
| AR022333A1 (es) * | 1999-01-26 | 2002-09-04 | Anitua Aldecoa Eduardo | Regenerador de tejido oseo |
| US7608258B2 (en) * | 2002-04-13 | 2009-10-27 | Allan Mishra | Method for treatment of tendinosis using platelet rich plasma |
| US6811777B2 (en) * | 2002-04-13 | 2004-11-02 | Allan Mishra | Compositions and minimally invasive methods for treating incomplete connective tissue repair |
| ES2221770B2 (es) | 2002-04-19 | 2006-07-16 | Eduardo Anitua Aldecoa | Metodo de preparacion de un compuesto para la regeneracion de tejidos. |
| US20060004189A1 (en) * | 2004-07-02 | 2006-01-05 | James Gandy | Compositions for treating wounds and processes for their preparation |
| WO2007025249A2 (en) * | 2005-08-26 | 2007-03-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for treatment of headaches by administration of oxytocin |
| JP2011504163A (ja) * | 2007-06-08 | 2011-02-03 | ヘルスパートナーズ リサーチ ファウンデーション | 中枢神経系への治療化合物の標的化を高めるための薬学的組成物および方法 |
| ES2333498B1 (es) * | 2007-08-02 | 2011-01-10 | Biotechnology Institute, I Mas D, S.L. | Metodo y compuesto para el tratamiento de enfermedades o dolencias articulares o para el tratamiento de la piel con fines esteticos u otros, y el metodo de preparacion del compuesto. |
| BRPI0816784A8 (pt) * | 2007-09-14 | 2016-01-19 | Scil Tech Gmbh | Fatores neuro-endócrinos para o tratamento de doenças degenerativas |
| PE20120317A1 (es) * | 2009-05-14 | 2012-04-16 | Biotechnology Inst I Mas D Sl | Metodo para la preparacion de al menos un compuesto a partir de sangre |
| KR101114712B1 (ko) * | 2009-10-23 | 2012-02-29 | 세원셀론텍(주) | 염화칼슘용액과 제1형 콜라겐으로 혈소판풍부혈장(ｐｒｐ)을 활성화하여 조직재생을 유도하는 조성물의 제조방법 |
| ES2369945B1 (es) * | 2011-07-29 | 2012-10-15 | Eduardo Anitua Aldecoa | Procedimiento de obtención de una composición que contiene factores de crecimiento a partir de un compuesto sanguíneo, y composición obtenible por dicho procedimiento. |
-
2012
- 2012-08-09 ES ES201200810A patent/ES2442242B1/es not_active Expired - Fee Related
-
2013
- 2013-07-19 TW TW102125858A patent/TWI649084B/zh not_active IP Right Cessation
- 2013-07-19 CN CN201380041280.4A patent/CN104519961A/zh active Pending
- 2013-07-19 BR BR112015002760A patent/BR112015002760A2/pt not_active Application Discontinuation
- 2013-07-19 EP EP13756518.0A patent/EP2883569B1/en not_active Not-in-force
- 2013-07-19 PE PE2015000116A patent/PE20150616A1/es not_active Application Discontinuation
- 2013-07-19 CA CA2881075A patent/CA2881075A1/en not_active Abandoned
- 2013-07-19 RU RU2015104076A patent/RU2696497C2/ru active
- 2013-07-19 JP JP2015525915A patent/JP6339568B2/ja not_active Expired - Fee Related
- 2013-07-19 KR KR1020157001551A patent/KR102149162B1/ko not_active Expired - Fee Related
- 2013-07-19 WO PCT/ES2013/000176 patent/WO2014023860A1/es not_active Ceased
- 2013-07-19 ES ES13756518.0T patent/ES2662385T3/es active Active
- 2013-07-19 MX MX2015001677A patent/MX357828B/es active IP Right Grant
- 2013-08-08 AR ARP130102835A patent/AR092086A1/es unknown
- 2013-08-08 US US13/962,340 patent/US20140044795A1/en not_active Abandoned
-
2014
- 2014-12-23 CL CL2014003510A patent/CL2014003510A1/es unknown
- 2014-12-31 IN IN2675MUN2014 patent/IN2014MN02675A/en unknown
-
2015
- 2015-01-20 CO CO15010369A patent/CO7170177A2/es unknown
-
2016
- 2016-03-08 US US15/063,969 patent/US20160184360A1/en not_active Abandoned
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018112672A1 (es) | 2016-12-21 | 2018-06-28 | Universidad De Chile | Virus aav/igf2, metodo de tratamiento genetico y su uso en enfermedades relacionadas con mal plegamiento de proteinas tal como la enfermedad de huntington |
Also Published As
| Publication number | Publication date |
|---|---|
| TW201408310A (zh) | 2014-03-01 |
| MX2015001677A (es) | 2015-04-10 |
| KR102149162B1 (ko) | 2020-08-31 |
| WO2014023860A1 (es) | 2014-02-13 |
| ES2662385T3 (es) | 2018-04-06 |
| ES2442242A1 (es) | 2014-02-10 |
| RU2696497C2 (ru) | 2019-08-02 |
| JP6339568B2 (ja) | 2018-06-06 |
| US20160184360A1 (en) | 2016-06-30 |
| IN2014MN02675A (enExample) | 2015-08-28 |
| AR092086A1 (es) | 2015-03-25 |
| CO7170177A2 (es) | 2015-01-28 |
| KR20150040860A (ko) | 2015-04-15 |
| ES2442242B1 (es) | 2014-11-25 |
| EP2883569B1 (en) | 2017-12-20 |
| TWI649084B (zh) | 2019-02-01 |
| RU2015104076A (ru) | 2016-09-27 |
| MX357828B (es) | 2018-07-25 |
| JP2015524464A (ja) | 2015-08-24 |
| CN104519961A (zh) | 2015-04-15 |
| EP2883569A1 (en) | 2015-06-17 |
| US20140044795A1 (en) | 2014-02-13 |
| CA2881075A1 (en) | 2014-02-13 |
| BR112015002760A2 (pt) | 2020-04-22 |
| PE20150616A1 (es) | 2015-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTC2785706I2 (lt) | Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui | |
| LT2887944T (lt) | Alopregnanolonas, skirtas atsparios epileptinės būklės gydymui | |
| LT3470063T (lt) | Farmacinės kompozicijos, skirtos cftr nulemtų ligų gydymui | |
| IL237275A0 (en) | Compounds for the treatment of paramoxovirus viral infections | |
| LT2916860T (lt) | Diabeto gydymui skirta kompozicija, apimanti oksintomodulino analogą | |
| HUE047198T2 (hu) | Fitokannabinoidok emlõrák kezelésére | |
| LT3292875T (lt) | Kompozicijos ir būdai, skirti ligų gydymui | |
| EP2906583A4 (en) | PEPTIDES FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES | |
| EP2738153A4 (en) | PROCESS FOR PREPARING 3,3-DIMETHYL-BUTYRALDEHYDE | |
| ZA201403430B (en) | 4-pregenen- 11ss -17 - 21-triols-3, 20- dione derivatives for the treatment of ocular conditions | |
| CO6900134A2 (es) | Tratamiento de mieloma múltiple | |
| SG10201703677VA (en) | Methods of treating s. aureus-associated diseases | |
| EP2937326A4 (en) | PREPARATION PROCESS FOR 1,3, 3,3-TETRAFLUORPROPEN | |
| LT2782602T (lt) | Nukleotidas dims0-150, skirtas lėtinio aktyvaus opinio kolito gydymui | |
| LT2939665T (lt) | Farmacinė kompozicija, skirta živ infekcijų gydymui | |
| HUE051295T2 (hu) | Módosított fibroblaszt növekedési faktorok-1 szembetegségek kezelésére | |
| GB201121940D0 (en) | Drug treating high blood pressure | |
| SG11201508061UA (en) | Artificial transcription factors for the treatment of diseases caused by opa1 haploinsufficiency | |
| EP2819995A4 (en) | PROCESS FOR THE PREPARATION OF 3-METHYLSULFONYLPROPIONITRIL | |
| IL234796B (en) | Compounds for the treatment of diseases related to ischemia-reperfusion | |
| ZA201302639B (en) | Antibodies for the treatment of hiv | |
| CL2014003510A1 (es) | Composición con factores de crecimiento obtenidos a partir del plasma sanguíneo destinada al tratamiento de enfermedades neurodegenerativas. | |
| IT1398032B1 (it) | Transferrina per il trattamento di malattie autoimmuni. | |
| IL235428A0 (en) | A process for the preparation of cyclic endopeptides | |
| HUP1200552A2 (en) | Pharmaceutical compositions for the treatment of high blood pressure |